Eric Schadt
Oprichter bij Mount Sinai Genomics, Inc.
Vermogen: 984 892 $ op 30-04-2024
Profiel
Eric E.
Schadt was the founder of GeneDx Holdings Corp.
(founded in 2021) and held the title of President, Chief Research & Development Officer.
Dr. Schadt is also the founder of Mount Sinai Genomics, Inc. Dr. Schadt's current job(s) include being a Director at Sage Bionetworks since 2009, a Director at 4YouandMe, and the Dean-Precision Medicine at Icahn School of Medicine at Mount Sinai since 2011.
Dr. Schadt's former job(s) include being an Executive Director at Merck & Co., Inc. from 2001 to 2009, an Executive Scientific Director at Rosetta Inpharmatics LLC, a Director at Station X, Inc., the Chief Scientific Officer at Pacific Biosciences of California, Inc. from 2009 to 2012, and a Senior Research Scientist at Roche Bioscience.
Dr. Schadt's education includes a doctorate from the University of California, Los Angeles, a graduate degree from the University of California, Davis, and an undergraduate degree from California Polytechnic State University (San Luis Obispo).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-04-2023 | 88 173 ( 0.34% ) | 984 892 $ | 30-04-2024 |
Actieve functies van Eric Schadt
| Bedrijven | Functie | Begin |
|---|---|---|
Mount Sinai Genomics, Inc.
 Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Oprichter | - |
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 01-08-2011 |
Sage Bionetworks
 Sage Bionetworks Miscellaneous Commercial ServicesCommercial Services Sage Bionetworks is a non-profit organization based in Seattle, WA that was founded in 2009 by Stephen H. Friend. The private company focuses on developing and applying open practices to data-driven research for the advancement of human health. The company's interdisciplinary team of scientists and engineers work together to provide researchers access to technology tools and scientific approaches to share data, benchmark methods, and explore collective insights, all backed by Sage's gold-standard governance protocols and commitment to user-centered design. Sage is a 501c3 and is supported through a portfolio of competitive research grants, commercial partnerships, and philanthropic contributions. | Directeur/Bestuurslid | 01-01-2009 |
4Youandme
 4Youandme Internet Software/ServicesTechnology Services 4YouandMe operates a platform for sharing health-related data. The company is based in Seattle, WA. The company was founded in 2017 by Stephen H. Friend. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Eric Schadt
| Bedrijven | Functie | Einde |
|---|---|---|
| GENEDX HOLDINGS CORP. | Algemeen Directeur | 29-04-2022 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Hoofd Techniek/Wetenschap/O&O | 16-07-2012 |
| MERCK & CO., INC. | Directeur/Bestuurslid | 01-05-2009 |
Station X, Inc.
 Station X, Inc. Packaged SoftwareTechnology Services Station X, Inc. develops software products for scientists and clinicians. It provides products to scientists who work with large-scale human genome information in either a research or clinical setting, enabling them to extract maximal biological meaning from complex genomic data. The company was founded by Richard D. Goold, Tod M. Klingler and Andrew R. MacBride in August 2010 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - |
Roche Bioscience
 Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a private company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Eric Schadt
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
| University of California, Davis | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| GENEDX HOLDINGS CORP. | Health Services |
| MERCK & CO., INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
Roche Bioscience
Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a private company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Health Technology |
Station X, Inc.
Station X, Inc. Packaged SoftwareTechnology Services Station X, Inc. develops software products for scientists and clinicians. It provides products to scientists who work with large-scale human genome information in either a research or clinical setting, enabling them to extract maximal biological meaning from complex genomic data. The company was founded by Richard D. Goold, Tod M. Klingler and Andrew R. MacBride in August 2010 and is headquartered in San Francisco, CA. | Technology Services |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Health Services |
Sage Bionetworks
Sage Bionetworks Miscellaneous Commercial ServicesCommercial Services Sage Bionetworks is a non-profit organization based in Seattle, WA that was founded in 2009 by Stephen H. Friend. The private company focuses on developing and applying open practices to data-driven research for the advancement of human health. The company's interdisciplinary team of scientists and engineers work together to provide researchers access to technology tools and scientific approaches to share data, benchmark methods, and explore collective insights, all backed by Sage's gold-standard governance protocols and commitment to user-centered design. Sage is a 501c3 and is supported through a portfolio of competitive research grants, commercial partnerships, and philanthropic contributions. | Commercial Services |
4Youandme
4Youandme Internet Software/ServicesTechnology Services 4YouandMe operates a platform for sharing health-related data. The company is based in Seattle, WA. The company was founded in 2017 by Stephen H. Friend. | Technology Services |
